2 months ago
33
ARTICLE AD BOX
NEW DELHI: The Centre has warned pharmaceutical companies against promoting medicine weight-loss GLP-1 drugs - popularly sold nether marque names Ozempic, Wegovy and Mounjaro - done advertisements oregon "disease awareness" campaigns that indirectly promote their usage among the public.In an advisory, Central Drugs Standard Control Organisation said it had travel to its announcement that immoderate firms were engaging successful nonstop oregon indirect promotional activities related to GLP-1 receptor agonists and akin medicine medicines utilized for obesity and metabolic conditions.The regulator said specified medicines could beryllium prescribed lone by registered aesculapian practitioners and immoderate effort to beforehand them to the wide nationalist could pull enactment nether the Drugs and Cosmetics Rules, 1945.
The advisory cautioned companies against advertisements that exaggerate their therapeutic benefits, warrant value nonaccomplishment oregon promote request for cause therapy portion downplaying manner changes specified arsenic diet, workout and behavioural interventions.The wellness authorities emphasised that obesity was a chronic metabolic information requiring broad management, including manner measures, and pharmaceutical therapy should not beryllium portrayed successful a mode that undermines nationalist wellness initiatives promoting carnal enactment and steadfast diet.
The regulator besides said that promotional campaigns presented arsenic "awareness initiatives" but functioning arsenic surrogate advertisements for medicine medicines would beryllium treated arsenic misleading selling practices.Drug manufacturers, importers and selling authorisation holders person been asked to strictly comply with Drugs and Cosmetics Act and related rules. The regulator directed companies to guarantee diligent accusation leaflets and prescribing accusation intelligibly show authorised interaction det-ails and grievance mechanisms. Firms person besides been asked to travel ethical selling practices and taxable risk-management plans.The advisory has been circulated to each stakeholders, including Advertising Standards Council of India, for compliance.
